Skip to Content

b 213 750 (Niacin extended-release 750 mg)

Pill with imprint b 213 750 is White, Capsule-shape and has been identified as Niacin extended-release 750 mg. It is supplied by Teva Pharmaceuticals USA Inc..

Niacin is used in the treatment of high cholesterol; depression; hyperlipoproteinemia type iv, elevated vldl; pellagra; niacin deficiency (and more), and belongs to the drug classes miscellaneous antihyperlipidemic agents, vitamins. Risk cannot be ruled out during pregnancy. Niacin 750 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for b 213 750

Niacin extended-release

b 213 750
750 mg
Rx and/or OTC
Drug Class:
Miscellaneous antihyperlipidemic agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA Inc.
National Drug Code (NDC):

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.